Objectives: To test CIDP patients for IgG positivity towards GDAP1L1.
Patients:
| NUMBER | CODE |
|---|---|
| 1 | 18-524 |
| 2 | 18-525 |
| 3 | 18-526 |
| 4 | 18-527 |
| 5 | 18-528 |
| 6 | 18-529 |
| 7 | 18-530 |
| 8 | 18-531 |
| 9 | 18-532 |
| 10 | 18-533 |
| 11 | 18-534 |
| 12 | 18-535 |
| 13 | 18-536 |
| 14 | 18-537 |
| 15 | 18-538 |
| 16 | 18-539 |
| 17 | 18-540 |
| 18 | 18-541 |
| 19 | 18-542 |
| 20 | 18-543 |
| 21 | 18-544 |
| 22 | 18-545 |
| 23 | 18-546 |
| 24 | CTRL - |
GDAP1L1 ICC:
- HEKs 293 Cells Transfection: 2018.01.22
- Blocking solution: 5% goat serum in PBS.
- Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
- Primary antibody: Mouse GDAP1L1 diluted 1/200
- Secondary antibodies: GAM488 (1/500) + GAH594 IgG (1/500).
- Vectashield mounting medium
Results: All samples were negative.
